T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Landstar System
LSTR
$6.4B
| $46M | 0.01% |
318,553
-1,206,792
| -79% | -$180M |
|
677
Palomar
PLMR
$3.37B
| $45.9M | 0.01% |
548,032
-1,052,287
| -66% | -$77.2M |
|
678
Simply Good Foods
SMPL
$989M
| $45.8M | 0.01% |
1,433,114
-1,505,782
| -51% | -$49.4M |
|
679
Fabrinet
FN
$20.3B
| $45.4M | 0.01% |
475,521
+21,866
| +5% | +$2.1M |
|
680
Iovance Biotherapeutics
IOVA
$2.95B
| $45.1M | 0.01% |
4,711,314
+360,629
| +8% | +$4.16M |
|
681
Johnson Controls International
JCI
$91.7B
| $44.8M | 0.01% |
910,088
-2,258
| -0.2% | -$120K |
|
682
Ryan Specialty Holdings
RYAN
$11B
| $44.7M | 0.01% |
1,100,853
-971,225
| -47% | -$41M |
|
683
Procept Biorobotics
PRCT
$1.26B
| $44.4M | 0.01% |
1,071,234
-2,832,769
| -73% | -$113M |
|
684
Papa John's
PZZA
$804M
| $44.4M | 0.01% |
633,559
-3,292,160
| -84% | -$279M |
|
685
Power Integrations
POWI
$3.48B
| $44.2M | 0.01% |
686,838
+4,321
| +0.6% | +$323K |
|
|
REVHU
686
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
| $44.1M | 0.01% |
4,491,865
-32,367
| -0.7% | -$318K |
|
687
Domino's
DPZ
$11.6B
| $44M | 0.01% |
141,747
-1,454,111
| -91% | -$552M |
|
688
Matador Resources
MTDR
$6.39B
| $43.9M | 0.01% |
896,440
-3,429,631
| -79% | -$185M |
|
689
Kadant
KAI
$3.91B
| $43.5M | 0.01% |
260,546
+1,187
| +0.5% | +$221K |
|
690
Concentrix
CNXC
$1.52B
| $43.1M | 0.01% |
386,348
+9,797
| +3% | +$1.25M |
|
691
Omnicell
OMCL
$1.72B
| $42.9M | 0.01% |
492,607
+2,855
| +0.6% | +$300K |
|
692
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.69B
| $42.8M | 0.01% |
343,490
| – | – |
|
693
Watts Water Technologies
WTS
$12.8B
| $42.8M | 0.01% |
340,416
+2,691
| +0.8% | +$365K |
|
694
PUT
Invesco Senior Loan ETF
BKLN
$6.76B
| $42.8M | 0.01% |
+2,119,700
| New | +$44.2M |
|
695
Carrier Global
CARR
$52.2B
| $42.5M | 0.01% |
1,194,210
+3,309
| +0.3% | +$130K |
|
696
Kinder Morgan
KMI
$71.4B
| $42.2M | 0.01% |
2,533,697
+3,259
| +0.1% | +$57.9K |
|
697
Prudential Financial
PRU
$43B
| $42.1M | 0.01% |
490,694
-1,562
| -0.3% | -$150K |
|
698
Fox Class A
FOXA
$27.5B
| $42.1M | 0.01% |
1,371,887
-2,893,601
| -68% | -$98M |
|
|
DAWN
699
DELISTED
Day One Biopharmaceuticals
DAWN
| $42M | 0.01% |
2,094,913
+53,569
| +3% | +$1.14M |
|
|
BCPC
700
Balchem Corp
BCPC
$5.65B
| $41.9M | 0.01% |
345,020
+127,686
| +59% | +$16.6M |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.